Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2023	Oct. 01, 2022
Cash flows from operating activities
Net income	$ 96,938	$ 261,243
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,378	12,557
Amortization of deferred financing fees	162	175
Equity-based compensation	10,943	7,753
Deferred taxes	(1,919)	3,318
Loss (gain) on disposal of property, plant, and equipment	96	(85)
Foreign currency transaction loss	76	974
Change in assets and liabilities:
Accounts receivable	12,101	7,633
Floor plan receivables	(2,521)	0
Inventories	20,059	11,540
Other assets	(13,434)	(14,489)
Accounts payable	4,387	(21,000)
Accrued expenses and other liabilities	(12,128)	8,947
Net cash provided by operating activities	129,138	278,566
Cash flows from investing activities
Additions to property, plant, and equipment	(22,847)	(25,613)
Cash paid for equity method investment	(1,000)	0
Cash paid for investment in ECN common stock	(78,858)	0
Cash paid for investment in ECN preferred stock	(64,520)	0
Investment in floor plan loans	(18,466)	0
Proceeds from floor plan loans	10,528	0
Acquisitions, net of cash acquired	0	(6,810)
Proceeds from disposal of property, plant, and equipment	524	132
Net cash used in investing activities	(174,639)	(32,291)
Cash flows from financing activities
Changes in floor plan financing, net	0	3,027
Stock option exercises	224	596
Tax payments for equity-based compensation	(982)	(1,363)
Net cash (used in) provided by financing activities	(758)	2,260
Effect of exchange rate changes on cash and cash equivalents	(39)	(6,944)
Net (decrease) increase in cash and cash equivalents	(46,298)	241,591
Cash and cash equivalents at beginning of period	747,453	435,413
Cash and cash equivalents at end of period	$ 701,155	$ 677,004